Fulgent Genetics, Inc. provided earnings guidance for the year 2024. For the year, The company expects total core revenues to be approximately $280 million for 2024, representing a core growth of 7% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 USD | -0.18% | +1.16% | -24.77% |
05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.77% | 651M | |
-15.77% | 8.49B | |
+58.90% | 4.08B | |
-39.78% | 2.42B | |
-10.16% | 2.42B | |
-3.46% | 2.33B | |
-2.53% | 2.01B | |
-19.90% | 1.53B | |
-38.30% | 1.26B | |
+2.19% | 1.07B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024